logo-loader
AIM:CIR OTC:CSSPF

Circassia Group PLC

Receive alerts
Market:
AIM
Price
-
Day Change
-
Market Cap:
-
52 weeks high
-
52 weeks low
-

In brief

Circassia is a specialty pharmaceutical company focused on respiratory disease. Our commercial organization promotes our innovative asthma management products directly to specialist physicians in a number of key markets, and we market the chronic obstructive pulmonary disease (COPD) products Tudorza® and Duaklir® in the United States. Recently, we significantly expanded our commercial platform in China, launching our own direct sales team. We are working to expand our portfolio further through in-licensing, partnering or acquisition, and in 2019 we acquired the commercial rights to the ventilator-compatible nitric oxide product LungFit PH* in the US and China.